（第八届进博会）在进博会看跨国企业创新范式 “全球资源+中国智慧”深度融合

中国新闻网11-06

中新网上海11月6日电 (记者陈静)6日正在此间举行的第八届中国国际进口博览会上，各个跨国企业展台琳琅满目的展品彰显“全球资源+中国智慧”深度融合的创新范式。　　连续八年参展的“全勤生”GE医疗中国首发新品数量、全球首秀规模及“中国创新浓度”均创下历届进博会参展新高。　　据悉，在18款首发新品中，60%为中国团队主导研发，9款实现全球首秀。其中，全球首秀的Expert X新量子CT和MR-PET...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2581583650?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-06 14:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581583650","market":"us","top_or_hot":-1,"title":"（第八届进博会）在进博会看跨国企业创新范式 “全球资源+中国智慧”深度融合","media":"中国新闻网","content":"<div>\n<p>中新网上海11月6日电 (记者陈静)6日正在此间举行的第八届中国国际进口博览会上，各个跨国企业展台琳琅满目的展品彰显“全球资源+中国智慧”深度融合的创新范式。　　连续八年参展的“全勤生”GE医疗中国首发新品数量、全球首秀规模及“中国创新浓度”均创下历届进博会参展新高。　　据悉，在18款首发新品中，60%为中国团队主导研发，9款实现全球首秀。其中，全球首秀的Expert X新量子CT和MR-PET...</p>\n\n<a href=\"http://biz.eastmoney.com/a/202511063556975278.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>（第八届进博会）在进博会看跨国企业创新范式 “全球资源+中国智慧”深度融合</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n（第八届进博会）在进博会看跨国企业创新范式 “全球资源+中国智慧”深度融合\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-06 14:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://biz.eastmoney.com/a/202511063556975278.html><strong>中国新闻网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>中新网上海11月6日电 (记者陈静)6日正在此间举行的第八届中国国际进口博览会上，各个跨国企业展台琳琅满目的展品彰显“全球资源+中国智慧”深度融合的创新范式。　　连续八年参展的“全勤生”GE医疗中国首发新品数量、全球首秀规模及“中国创新浓度”均创下历届进博会参展新高。　　据悉，在18款首发新品中，60%为中国团队主导研发，9款实现全球首秀。其中，全球首秀的Expert X新量子CT和MR-PET...</p>\n\n<a href=\"http://biz.eastmoney.com/a/202511063556975278.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999002232.USD","symbol_name":"Allianz Global High Payout USD","start_time":0,"source_url":"http://biz.eastmoney.com/a/202511063556975278.html","article_id":"2581583650","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://biz.eastmoney.com/a/202511063556975278.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2581583650","pubTimestamp":1762411209,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"中新网上海11月6日电(记者陈静)6日正在此间举行的第八届中国国际进口博览会上，各个跨国企业展台琳琅满目的展品彰显“全球资源+中国智慧”深度融合的创新范式。连续八年参展的“全勤生”GE医疗中国首发新品数量、全球首秀规模及“中国创新浓度”均创下历届进博会参展新高。据悉，在18款首发新品中，60%为中国团队主导研发，9款实现全球首秀。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"SG9999002232.USD":"Allianz Global High Payout USD","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","SG9999002224.SGD":"Allianz Global High Payout SGD","BK4581":"高盛持仓","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4599":"减肥药","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","BK4007":"制药","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU1883839398.USD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","AD":"Array Digital Infrastructure Inc.","BK4533":"AQR资本管理(全球第二大对冲基金)","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0306807586.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" (USD) INC QF","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","LU0122379950.USD":"贝莱德世界健康科学A2","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU0234572021.USD":"高盛美国核心股票组合Acc","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU0058720904.USD":"联博国际健康护理基金A","BK4132":"无线电信业务","BK4592":"伊斯兰概念","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","PFE":"辉瑞","BK4568":"美国抗疫概念","BK4588":"碎股","BK4550":"红杉资本持仓","SG9999001176.USD":"United Global Healthcare Acc USD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus"},"translate_title":"(The 8th China International Import Expo) Looking at the deep integration of multinational enterprise innovation paradigm \"global resources + Chinese wisdom\" in China International Import Expo","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AD":1,"PFE":0.9},"content_text":"中新网上海11月6日电 (记者陈静)6日正在此间举行的第八届中国国际进口博览会上，各个跨国企业展台琳琅满目的展品彰显“全球资源+中国智慧”深度融合的创新范式。　　连续八年参展的“全勤生”GE医疗中国首发新品数量、全球首秀规模及“中国创新浓度”均创下历届进博会参展新高。　　据悉，在18款首发新品中，60%为中国团队主导研发，9款实现全球首秀。其中，全球首秀的Expert X新量子CT和MR-PET实时代谢磁共振一经亮相，便获得众多关注。　　作为GE医疗超高端量子平台CT家族新成员，Expert X新量子CT由中国团队主导研发，4D心脏成像技术可实现毫秒级连续采集图像，实现“全心动周期”可视化，大幅提升冠心病合并瓣膜病等复杂病例的诊断效率，进一步提升手术精准度。同时，搭载第三代多核深度学习重建引擎的Expert X新量子CT，针对心脏、肺部等需要更高图像精度的检查部位，可通过AI驱动进一步扩展高精度影像能力。　　此次在进博会完成全球首秀的MR-PET无辐射实时代谢磁共振，在临床级磁共振平台上首次实现了代谢信息的实时、无辐射成像，将MR影像诊断从“看结构”推升至“看代谢”的新维度，不仅为肿瘤、神经退行性病变等重大疾病的精准诊疗开辟新路径，还通过诊断窗口显著前移、治疗方案的早期评估与动态优化，切实提升临床决策的效率与质量。该MR-PET无辐射实时代谢磁共振平台已落地GE医疗天津基地生产。全球首秀后，该技术正式迈向临床应用新阶段，并将助力更多医疗机构实现从\"临床跟随\"到\"科研并跑\"的能力跨越。　　在雅培展台，记者看到十余款首秀产品，涵盖全球领先的生物可穿戴传感技术、高效安全的微创诊疗、个性化的诊断解决方案等。Volt PFA一次性使用磁电定位压力监测球囊脉冲电场消融导管是一项革命性房颤治疗技术，可高效锁定并精准消除异常心脏电信号，显著降低消融治疗风险；Diamondback360冠状动脉轨道旋磨介入治疗系统可在冠脉钙化病变治疗中通过高速旋转的钻石涂层旋磨头消除血管钙化斑块，击碎血管“拦路石”等。　　在辉瑞的展台，记者看到特应性皮炎治疗产品希必可(阿布昔替尼片)、舒坦明(克立硼罗软膏)和斑秃创新疗法乐复诺(甲苯磺酸利特昔替尼胶囊)。特应性皮炎(AD)是一种慢性、炎症性、复发性的皮肤疾病，在中国发病率呈逐年上升趋势。本届进博会上，辉瑞炎症与免疫事业部启动了一系列合作及创新科技平台。　　辉瑞中国炎症与免疫事业部总经理刘菁对记者表示：“今年是辉瑞携创新产品亮相进博会的第7年。炎症与免疫是辉瑞重要的战略布局领域，作为全球首个研发炎症免疫性疾病JAK通路的生物制药公司，我们持续开展真实世界研究，深耕中国，为全球临床诊疗提供重要参考。”该企业主导的AHEAD研究是全球最大规模JAK1抑制剂真实世界研究，目前已纳入超千例中国患者。　　据悉，进博会期间，辉瑞与上药控股有限公司、雍禾医疗集团、京东健康、镁信健康达成战略合作，共同构建覆盖“从疾病教育到用药服务”的线上线下、院内院外一体化全渠道服务体系，以互联互通的创新模式助力斑秃患者诊疗体验全面升级，推进皮肤科高质量发展。(完)（文章来源：中国新闻网）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2581583650","isCrawlerRequest":true}